(2R,5R)-5-benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one, 97%, 5g

3-Chloro-4-(1H-pyrazol-1-yl)benzaldehyde, 95.0%, 1g

4-(HYDRAZINYLMETHYL)-1-METHYL-1H-PYRAZOLE 3HCL, 95.0%, 5g

3-(3-Methoxyphenyl)propionic acid, 98.0%, 500g

4-(Methylthio)aniline, 97.0%, 100g

4-BROMO-2-FLUORO-N-(4-METHYLTHIAZOL-2-YL)BENZENESULFONAMIDE, 95.0%, 250mg

Val-Cit-PAB-MMAE, 99%, 100mg

2-Chloro-N-methylpyrimidin-4-amine, 97.0%, 10g

4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)-METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 5g

Gentiopicroside, min. 95%, for biochemistry, 10 mg, glass packaging

(S)-3-Amino-4-((carboxymethyl)amino)-4-oxobutanoic acid, 95%, 100mg

5-phenyl-4,5-dihydroisoxazole-3-carboxylic acid, 95.0%, 10g

L-cysteine hydrochloride, min. 98%, pa, anhydrous, 250 g, plastic packaging.